UNIVERSI
TÄ
TS-
BIBLIOTHEK
P
ADERBORN
Anmelden
Menü
Menü
Start
Hilfe
Blog
Weitere Dienste
Neuerwerbungslisten
Fachsystematik Bücher
Erwerbungsvorschlag
Bestellung aus dem Magazin
Fernleihe
Einstellungen
Sprache
Deutsch
Deutsch
Englisch
Farbschema
Hell
Dunkel
Automatisch
Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist
gegebenenfalls
nur via VPN oder Shibboleth (DFN-AAI) möglich.
mehr Informationen...
Universitätsbibliothek
Katalog
Suche
Details
Zur Ergebnisliste
Ergebnis 5 von 1104
Datensatz exportieren als...
BibTeX
Plasma Biomarkers and Positron Emission Tomography Tau Pathology in Progressive Supranuclear Palsy
Movement disorders, 2023-04, Vol.38 (4), p.676-682
Huang, Shu‐Yi
Chen, Shu‐Fen
Cui, Mei
Zhao, Meng
Shen, Xue‐Ning
Guo, Yu
Zhang, Ya‐Ru
Zhang, Wei
Wang, Hui‐Fu
Huang, Yu‐Yuan
Cheng, Wei
Zuo, Chuan‐Tao
Dong, Qiang
Yu, Jin‐Tai
2023
Volltextzugriff (PDF)
Details
Autor(en) / Beteiligte
Huang, Shu‐Yi
Chen, Shu‐Fen
Cui, Mei
Zhao, Meng
Shen, Xue‐Ning
Guo, Yu
Zhang, Ya‐Ru
Zhang, Wei
Wang, Hui‐Fu
Huang, Yu‐Yuan
Cheng, Wei
Zuo, Chuan‐Tao
Dong, Qiang
Yu, Jin‐Tai
Titel
Plasma Biomarkers and Positron Emission Tomography Tau Pathology in Progressive Supranuclear Palsy
Ist Teil von
Movement disorders, 2023-04, Vol.38 (4), p.676-682
Ort / Verlag
Hoboken, USA: John Wiley & Sons, Inc
Erscheinungsjahr
2023
Quelle
Wiley Online Library Journals Frontfile Complete
Beschreibungen/Notizen
ABSTRACT Background Development of disease‐modifying therapeutic trials of progressive supranuclear palsy (PSP) urges the need for sensitive fluid biomarkers. Objectives The objectives of this study were to explore the utility of plasma biomarkers in the diagnosis, differential diagnosis, and assessment of disease severity, brain atrophy, and tau deposition in PSP. Methods Plasma biomarkers were measured using a single‐molecule array in a cohort composed of patients with PSP, Parkinson's disease (PD), multiple system atrophy with predominant parkinsonism (MSA‐P), and healthy controls (HCs). Results Plasma neurofilament light chain (NfL) outperformed other plasma makers (ie, glial fibrillary acidic protein [GFAP], phosphorylated‐tau 181 [p‐tau181], amyloid‐β 1–40, amyloid‐β 1–42) in identifying PSP from HC (area under the curve [AUC] = 0.904) and from MSA‐P (AUC = 0.711). Plasma GFAP aided in distinguishing PSP from HC (AUC = 0.774) and from MSA‐P (AUC = 0.832). It correlated with brainstem atrophy and higher regional tau accumulation. However, plasma p‐tau181 neither helped in diagnosis nor was it associated with clinical or neuroimaging measures. Conclusions Plasma NfL and GFAP showed different values in differentiating PSP from HC or controls with other forms of neurodegenerative parkinsonism and detecting disease severity, brain atrophy, or tau deposition in PSP. © 2023 International Parkinson and Movement Disorder Society. Plasma neurofilament light chain (NfL) is a promising biomarker of progressive supranuclear palsy (PSP) to assist in PSP diagnosis and differential diagnosis from Parkinson's disease (PD) and to monitor disease severity. Pending replication in independent cohorts, plasma glial fibrillary acidic protein (GFAP) holds promise for a PSP diagnosis and a differential diagnosis with multiple system atrophy with predominant parkinsonism (MSA‐P) and for detecting brainstem atrophy and tau deposition in PSP.
Sprache
Englisch
Identifikatoren
ISSN: 0885-3185
eISSN: 1531-8257
DOI: 10.1002/mds.29339
Titel-ID: cdi_proquest_miscellaneous_2776515641
Format
–
Schlagworte
Alzheimer's disease
,
Atrophy
,
Basal ganglia
,
Biomarkers
,
Brain stem
,
Central nervous system diseases
,
Clinical trials
,
Differential diagnosis
,
Glial fibrillary acidic protein
,
Humans
,
Movement disorders
,
Multiple System Atrophy - diagnosis
,
Neurodegenerative diseases
,
Neuroimaging
,
Neuronal-glial interactions
,
Paralysis
,
Parkinson Disease - diagnosis
,
Parkinson's disease
,
Parkinsonian Disorders - diagnostic imaging
,
Parkinsonian Disorders - pathology
,
Plasma
,
Positron emission tomography
,
Positron-Emission Tomography - methods
,
Progressive supranuclear palsy
,
Supranuclear Palsy, Progressive - diagnosis
,
Tau protein
,
tau Proteins - metabolism
,
β-Amyloid
Weiterführende Literatur
Empfehlungen zum selben Thema automatisch vorgeschlagen von
bX